首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   132368篇
  免费   8362篇
  国内免费   2329篇
耳鼻咽喉   1653篇
儿科学   3320篇
妇产科学   4280篇
基础医学   19144篇
口腔科学   3810篇
临床医学   10986篇
内科学   22902篇
皮肤病学   2747篇
神经病学   8338篇
特种医学   4546篇
外国民族医学   3篇
外科学   17924篇
综合类   8586篇
现状与发展   4篇
一般理论   34篇
预防医学   10305篇
眼科学   2937篇
药学   11798篇
  21篇
中国医学   2231篇
肿瘤学   7490篇
  2022年   950篇
  2021年   1567篇
  2020年   1090篇
  2019年   1344篇
  2018年   1906篇
  2017年   1519篇
  2016年   1466篇
  2015年   1952篇
  2014年   2566篇
  2013年   3373篇
  2012年   4735篇
  2011年   5049篇
  2010年   3387篇
  2009年   3048篇
  2008年   4311篇
  2007年   4574篇
  2006年   4410篇
  2005年   3784篇
  2004年   3413篇
  2003年   3151篇
  2002年   2911篇
  2001年   6986篇
  2000年   7100篇
  1999年   5773篇
  1998年   1885篇
  1997年   1439篇
  1996年   995篇
  1992年   3747篇
  1991年   3826篇
  1990年   3567篇
  1989年   3562篇
  1988年   3445篇
  1987年   3293篇
  1986年   3101篇
  1985年   2971篇
  1984年   2056篇
  1983年   1795篇
  1982年   991篇
  1979年   1916篇
  1978年   1190篇
  1977年   988篇
  1976年   919篇
  1975年   1193篇
  1974年   1359篇
  1973年   1417篇
  1972年   1362篇
  1971年   1250篇
  1970年   1139篇
  1969年   1123篇
  1968年   1024篇
排序方式: 共有10000条查询结果,搜索用时 19 毫秒
21.
目的用FQ-RT-PCR技术检测外周血中hnRNPA2/B1表达水平及在肺癌诊断中的意义.方法用FQ-RT-PCR技术定量分别检测18例健康体检者、12例肺部良性疾病和30例肺癌患者外周血中hnRNPA2/B1 mRNA,并用β-actin对hnRNPA2/B1表达水平进行标化.结果 hnRNPA2/B1与β-actin的比值在正常对照组和良性肺部疾病组间差异无显著性(P>0.05),而肺癌组均高于前两组(P<0.05);hnRNPA2/B1基因在低分化鳞癌中的表达水平很低,与其它类型肺癌差异有显著性(P<0.05).结论 hnRNPA2/B1在血中表达水平的差异在肺癌诊断中具有一定临床应用价值,并与肺癌的病理分级有一定相关性.  相似文献   
22.
23.
ObjectivesHigh-quality diagnosis of bloodstream infections (BSI) is important for successful patient management. As knowledge on current practices of microbiological BSI diagnostics is limited, this project aimed to assess its current state in European microbiological laboratories.MethodsWe performed an online questionnaire-based cross-sectional survey comprising 34 questions on practices of microbiological BSI diagnostics. The ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES) was the primary platform to engage national coordinators who recruited laboratories within their countries.ResultsResponses were received from 209 laboratories in 25 European countries. Although 32.5% (68/209) of laboratories only used the classical processing of positive blood cultures (BC), two-thirds applied rapid technologies. Of laboratories that provided data, 42.2% (78/185) were able to start incubating BC in automated BC incubators around-the-clock, and only 13% (25/192) had established a 24-h service to start immediate processing of positive BC. Only 4.7% (9/190) of laboratories validated and transmitted the results of identification and antimicrobial susceptibility testing (AST) of BC pathogens to clinicians 24 h/day. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry from briefly incubated sub-cultures on solid media was the most commonly used approach to rapid pathogen identification from positive BC, and direct disc diffusion was the most common rapid AST method from positive BC.ConclusionsLaboratories have started to implement novel technologies for rapid identification and AST for positive BC. However, progress is severely compromised by limited operating hours such that current practice of BC diagnostics in Europe complies only partly with the requirements for optimal BSI management.  相似文献   
24.
The revised International Staging System (R-ISS) combines ISS with genetic markers and lactate dehydrogenase and can prognosticate newly diagnosed multiple myeloma (MM). Early relapse (<24 months) after upfront autologous hematopoietic cell transplantation (AHCT) strongly predicts inferior overall survival (OS). We examined the ability of R-ISS in predicting early relapse and its independent prognostic effect on postrelapse survival after an early relapse. Using the Center for International Blood and Marrow Transplant Research database we identified MM patients receiving first AHCT within 18 months after diagnosis with available R-ISS stage at diagnosis (n?=?628). Relative risks of relapse/progression, progression-free survival (PFS), and OS were calculated with the R-ISS group as a predictor in multivariate analysis. Among early relapsers, postrelapse survival was tested to identify factors affecting postrelapse OS. The cumulative incidence of early relapse was 23%, 39%, and 50% for R-ISS I, R-ISS II, and R-ISS III, respectively (P < .001). Shorter PFS and OS were seen with higher stage R-ISS. R-ISS was independently predictive for inferior postrelapse OS among early relapsers, as was the presence of ≥3 comorbidities and the use of ≥2 induction chemotherapy lines. R-ISS stage at diagnosis predicts early post-AHCT relapse and independently affects postrelapse survival among early relapsers.  相似文献   
25.
26.
27.
Neuroscience and Behavioral Physiology - Objective. To assess the dynamics of recovery of motor, speech, and autonomous functions in patients with ischemic stroke (IS) using music therapy....  相似文献   
28.
29.
Summary.  The interaction between the vulnerable atherosclerotic plaque prone to disruption and thrombus formation is the cornerstone of acute coronary syndrome (ACS). Although distinct from one another, the atherosclerotic and thrombotic processes appear to be interdependent, hence the term atherothrombosis. Inflammation is a crucial common pathophysiological mechanism. Overall, the association of plaque vulnerability and ACS has been well documented. Given the multifactorial origin of atherothrombosis the best preventive approach should be aggressive management of all the risk factors. New interventions should be directed toward decreasing vulnerability of the lesions thereby decreasing the risk of ACS.  相似文献   
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号